Literature DB >> 25139656

Hereditary cancer syndromes with high risk of endometrial and ovarian cancer: surgical options for personalized care.

Georgia A McCann1, Eric L Eisenhauer.   

Abstract

Cancer genomics has increased our recognition of specific hereditary cancer mutations. Hereditary breast and ovarian cancer (HBOC) syndrome and Lynch syndrome are two such entities in which women carrying specific mutations may be at high risk for developing breast, ovarian, and/or endometrial cancers. Risk reducing surgery such as prophylactic mastectomy, oophorectomy, and/or hysterectomy may allow women to decrease these risks after completing childbearing. Background, indications, and consequences of these procedures are reviewed.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  BRCA; hereditary cancer; lynch

Mesh:

Year:  2014        PMID: 25139656     DOI: 10.1002/jso.23743

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  Quality of life following prophylactic gynecological surgery: experiences of female Lynch mutation carriers.

Authors:  Holly Etchegary; Elizabeth Dicks; Laura Tamutis; Lesa Dawson
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

2.  Decisions about prophylactic gynecologic surgery: a qualitative study of the experience of female Lynch syndrome mutation carriers.

Authors:  Holly Etchegary; Elizabeth Dicks; Kathy Watkins; Sabrina Alani; Lesa Dawson
Journal:  Hered Cancer Clin Pract       Date:  2015-03-19       Impact factor: 2.857

3.  Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary Thyroid Cancer.

Authors:  Yang Yu; Li Dong; Dapeng Li; Shaokun Chuai; Zhigang Wu; Xiangqian Zheng; Yanan Cheng; Lei Han; Jinpu Yu; Ming Gao
Journal:  Sci Rep       Date:  2015-11-04       Impact factor: 4.379

Review 4.  Practical aspects of NGS-based pathways analysis for personalized cancer science and medicine.

Authors:  Ekaterina A Kotelnikova; Mikhail Pyatnitskiy; Anna Paleeva; Olga Kremenetskaya; Dmitriy Vinogradov
Journal:  Oncotarget       Date:  2016-08-09

5.  Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts.

Authors:  Alanna Kulchak Rahm; Deborah Cragun; Jessica Ezzell Hunter; Mara M Epstein; Jan Lowery; Christine Y Lu; Pamala A Pawloski; Ravi N Sharaf; Su-Ying Liang; Andrea N Burnett-Hartman; James M Gudgeon; Jing Hao; Susan Snyder; Radhika Gogoi; Ilene Ladd; Marc S Williams
Journal:  BMC Health Serv Res       Date:  2018-10-30       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.